Treatment of aspergillus infections with thymosin alpha 1

Details for Australian Patent Application No. 2004226403 (hide)

Owner SciClone Pharmaceuticals, Inc.

Inventors Garaci, Enrico; Romani, Luigina; Rasi, Guido; Bistoni, Francesco; Di Francesco, Paolo

Agent Wrays

Pub. Number AU-B-2004226403

PCT Pub. Number WO2004/087067

Priority 60/457,911 28.03.03 US

Filing date 29 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 4 December 2008

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087067 Priority application(s): WO2004/087067

4 December 2008 Application Accepted

  Published as AU-B-2004226403

2 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226417-Methods of treating diabetes by blocking VEGF-mediated activity

2004226398-Methods and apparatus for treatment of patent foramen ovale